Correlation Between DiaMedica Therapeutics and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on DiaMedica Therapeutics and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Alnylam Pharmaceuticals.
Diversification Opportunities for DiaMedica Therapeutics and Alnylam Pharmaceuticals
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between DiaMedica and Alnylam is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Alnylam Pharmaceuticals
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 2.28 times more return on investment than Alnylam Pharmaceuticals. However, DiaMedica Therapeutics is 2.28 times more volatile than Alnylam Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 165.00 in DiaMedica Therapeutics on January 26, 2024 and sell it today you would earn a total of 80.00 from holding DiaMedica Therapeutics or generate 48.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Alnylam Pharmaceuticals |
DiaMedica Therapeutics and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Alnylam Pharmaceuticals
The main advantage of trading using opposite DiaMedica Therapeutics and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase TherapeuticsInc | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |